MARKETS
Analyst Actions

RBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

Oct 29, 2026 · 03:53 PM ET· updated 17h ago

RBC Capital analyst Kendall Au maintains GE HealthCare Techs (NASDAQ:GEHC) with a Outperform and raises the price target from $80 to $90.

Share
Why It Matters

An expert analyst thinks GE HealthCare is a good company to own. They raised their price target from $80 to $90, meaning they see room for growth.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.